investorscraft@gmail.com

Stock Analysis & ValuationCaris Life Sciences, Inc. (CAI)

Previous Close
$23.16
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

750 West John Carpenter Freeway
Irving, TX 75039
United States
Phone: 866 771 8946
Industry: Biotechnology
Sector: Healthcare
CEO: David Dean Halbert
Full Time Employees: 1769

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

HomeMenuAccount